West Pharmaceutical Services, Inc.
NYSEWest Pharmaceutical Services enters its May 4 Q1 2026 earnings call having staged a remarkable comeback — up 21% over the past month to $297.59 — yet peers in the life sciences tools space spent last week in retreat. The contrast with peers is the first thing that stands out. While WST gained about 0.8% on Thursday, close correlates such as A fell 3.1%…
Snapshot as of 8 May 2026
West Pharmaceutical Services enters its May 4 Q1 2026 earnings call having staged a remarkable comeback — up 21% over the past month to $297.59 — yet peers in the life sciences tools space spent last week in…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for WST — free to start on ORTEX.
Sign up for free →Open WST on ORTEX